Citation: N. Yamamoto et Vr. Naraparaju, STRUCTURALLY WELL-DEFINED MACROPHAGE ACTIVATING FACTOR DERIVED FROM VITAMIN-D-3-BINDING PROTEIN HAS A POTENT ADJUVANT ACTIVITY FOR IMMUNIZATION, Immunology and cell biology, 76(3), 1998, pp. 237-244
Citation: M. Korbelik et al., THE VALUE OF SERUM ALPHA-N-ACETYL GALACTOSAMINIDASE MEASUREMENT FOR THE ASSESSMENT OF TUMOR RESPONSE TO RADIODYNAMIC AND PHOTODYNAMIC THERAPY, British Journal of Cancer, 77(6), 1998, pp. 1009-1014
Citation: N. Yamamoto et Vr. Naraparaju, HUMAN-IMMUNODEFICIENCY-VIRUS CODES FOR ALPHA-N-ACETYLGALACTOSAMINIDASE THAT PLAYS A ROLE IN IMMUNOSUPPRESSION, The FASEB journal, 11(9), 1997, pp. 730-730
Citation: Vr. Naraparaju et N. Yamamoto, TUMOR-DERIVED ALPHA-N-ACETYLGALACTOSAMINIDASE AND ITS ROLE IN IMMUNOSUPPRESSION, The FASEB journal, 11(9), 1997, pp. 2331-2331
Authors:
YAMAMOTO N
NARAPARAJU VR
MOORE M
BRENT LH
Citation: N. Yamamoto et al., DEGLYCOSYLATION OF SERUM VITAMIN-D-3-BINDING PROTEIN BY ALPHA-N-ACETYLGALACTOSAMINIDASE DETECTED IN THE PLASMA OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Clinical immunology and immunopathology, 82(3), 1997, pp. 290-298
Citation: N. Yamamoto et al., PROGNOSTIC UTILITY OF SERUM ALPHA-N-ACETYLGALACTOSAMINIDASE AND IMMUNOSUPPRESSION RESULTED FROM DEGLYCOSYLATION OF SERUM GC PROTEIN IN ORAL-CANCER PATIENTS, Cancer research, 57(2), 1997, pp. 295-299
Citation: N. Yamamoto et Vr. Naraparaju, IMMUNOTHERAPY OF BALB C MICE BEARING EHRLICH ASCITES TUMOR WITH VITAMIN-D-BINDING PROTEIN-DERIVED MACROPHAGE ACTIVATING FACTOR/, Cancer research, 57(11), 1997, pp. 2187-2192
Citation: M. Korbelik et al., MACROPHAGE-DIRECTED IMMUNOTHERAPY AS ADJUVANT TO PHOTODYNAMIC THERAPYOF CANCER, British Journal of Cancer, 75(2), 1997, pp. 202-207
Citation: N. Yamamoto et Vr. Naraparaju, A DEFECT IN BETA-GALACTOSIDASE OF B-LYMPHOCYTES IN THE OSTEOPETROTIC (OP OP) MOUSE/, Immunology letters, 50(1-2), 1996, pp. 35-40
Citation: N. Yamamoto et Vr. Naraparaju, ROLE OF VITAMIN-D-3-BINDING PROTEIN IN ACTIVATION OF MOUSE MACROPHAGES, The Journal of immunology, 157(4), 1996, pp. 1744-1749
Citation: N. Yamamoto et Vr. Naraparaju, A DEFECT IN INDUCIBLE BETA-GALACTOSIDASE OF B-LYMPHOCYTES IN THE OSTEOPETROTIC (MI MI) MOUSE/, Immunology, 88(4), 1996, pp. 604-610
Citation: N. Yamamoto et Vr. Naraparaju, VITAMIN D-3-BINDING PROTEIN AS A PRECURSOR FOR MACROPHAGE ACTIVATING FACTOR IN THE INFLAMMATION-PRIMED MACROPHAGE ACTIVATION CASCADE IN RATS, Cellular immunology, 170(2), 1996, pp. 161-167
Citation: N. Yamamoto et al., DEGLYCOSYLATION OF SERUM VITAMIN-D-3 BINDING-PROTEIN LEADS TO IMMUNOSUPPRESSION IN CANCER-PATIENTS, Cancer research, 56(12), 1996, pp. 2827-2831
Citation: N. Yamamoto et al., DEFECTIVE LYMPHOCYTE GLYCOSIDASES IN THE MACROPHAGE ACTIVATION CASCADE OF JUVENILE OSTEOPETROSIS, Blood, 88(4), 1996, pp. 1473-1478
Citation: N. Yamamoto et al., STRUCTURAL MODIFICATION OF SERUM VITAMIN-D-3-BINDING PROTEIN AND IMMUNOSUPPRESSION IN AIDS PATIENTS, AIDS research and human retroviruses, 11(11), 1995, pp. 1373-1378
Authors:
YAMAMOTO N
NARAPARAJU VR
SRINIVASULA SM
BRENT LH
Citation: N. Yamamoto et al., ACTIVATION OF MACROPHAGES BY GCMAF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 38(6), 1995, pp. 26-26
Citation: Vr. Naraparaju et N. Yamamoto, ROLES OF BETA-GALACTOSIDASE OF B-LYMPHOCYTES AND SIALIDASE OF T-LYMPHOCYTES IN INFLAMMATION-PRIMED ACTIVATION OF MACROPHAGES, Immunology letters, 43(3), 1994, pp. 143-148
Authors:
YAMAMOTO N
LINDSAY DD
NARAPARAJU VR
IRELAND RA
POPOFF SN
Citation: N. Yamamoto et al., A DEFECT IN THE INFLAMMATION-PRIMED MACROPHAGE-ACTIVATION CASCADE IN OSTEOPETROTIC RATS, The Journal of immunology, 152(10), 1994, pp. 5100-5107
Authors:
POPOFF SN
LINDSAY DD
NARAPARAJU VR
IRELAND RA
YAMAMOTO N
Citation: Sn. Popoff et al., DEFECTIVE OSTEOCLAST AND MACROPHAGE ACTIVATION IN THE OSTEOPETROTIC (OP) RAT, Journal of bone and mineral research, 8, 1993, pp. 190000140-190000140